1.Research advance of PDSS2 gene on carcinoma
Chinese Journal of Pathophysiology 2016;32(9):1713-1717
[ ABSTRACT] Prenyl diphosphate synthase subunit 2 ( PDSS2), which encodes the second subunit of prenyl diphosphate synthase, an essential enzyme involved in the biosynthesis of coenzyme Q10 (CoQ10), is almost expressed in all tissues and organs at different developmental stages of human beings.The abnormal expression of PDSS2 may result in many diseases through impacting the biosynthesis of CoQ10.Recent studies show that PDSS2 gene has decreased in mela-noma, gastric cancer, lung cancer and hepatocellular carcinoma, and the degree of reduced level is closely related to the clinical features, which enlighten us that PDSS2 maybe a tumor suppressor gene involves in the development and progres-sion of carcinoma.This review aims to introduce the recent research progress about PDSS2 gene on carcinoma, discuss its roles and value on cancer research.
2.Ouabain and asthenospermia.
National Journal of Andrology 2015;21(12):1129-1133
Asthenospermia accounts for about 30% of the causes of male infertility. Currently, most drugs for asthenospermia lack specificity and desirable therapeutic efficiency. An insight into the pathogenesis of asthenospermia is important for the development of specific therapies for this disease. The protein Na+/K(+)- ATPase α4 isoform (NKA4) presents in both mature testis tissue and the sperm tail, the absence or reduced activity of which may significantly decrease sperm motility. Ouabain is a natural inhibitor of NKA4, suppressing its activity by specifically binding the ouabain site in it. The hypothalamus and adrenal cortex excrete an ouabain-like steroid hormone called endogenous ouabain (EO), which may be associated with the pathogenesis of asthenospermia by inhibiting the activity of NKA4, affecting Na+/H+ exchange, Na+/Ca2+ exchange and sperm cell membrane potential, and eventually reducing sperm motility.
Asthenozoospermia
;
physiopathology
;
Humans
;
Male
;
Membrane Potentials
;
Ouabain
;
chemistry
;
Protein Isoforms
;
Sodium-Potassium-Exchanging ATPase
;
antagonists & inhibitors
;
Sperm Motility
;
Sperm Tail
;
Spermatozoa
;
Testis
4.More efforts should be made to improve the level of diagnosis and treatment of infectious diseases of newborn infants.
Chinese Journal of Pediatrics 2003;41(12):881-883
Anti-Bacterial Agents
;
therapeutic use
;
Bacterial Infections
;
diagnosis
;
therapy
;
China
;
Communicable Diseases
;
diagnosis
;
therapy
;
Cross Infection
;
prevention & control
;
therapy
;
Granulocyte Colony-Stimulating Factor
;
therapeutic use
;
Granulocyte-Macrophage Colony-Stimulating Factor
;
therapeutic use
;
Humans
;
Immunoglobulins, Intravenous
;
therapeutic use
;
Infant, Newborn
;
Sepsis
;
diagnosis
;
therapy
5.Multicentric angiofollicular lymph node hyperplasia:clinical and pathological characteristics of eight cases
Tong ZHANG ; Kaidan HUANG ; Xinyu XU
China Oncology 2001;11(2):113-116
Purpose:To study the clinical and pathological characteristics of multicentric angiofollicular lymph node hyperplasia (MCD).Methods:Eight patients with histologic diagnosis of angiofollicular lymph node hyperplasia (CD) were identified in the pathologic data base.The lymph node lesions were categorized as PC,Mix and HV types according to the criteria described by Frizzera. Patient with MCD had to have histology of CD within at least one regional group of lymph nodes and all underwent extensive lymphadenectomy.Results:The histologic features of 8 patients were six with PC,one with Mix and one with HV.Five patients presented with systemic symptoms. Three patients had splenomegaly and hapatomegaly. Five patients had local recurrence.Conclusions:MCD tends to recur and has a progressive clinical course with potential for malignancy ,and further study is needed to clarify the pathogenesis. Close follow-up and periodic surveillance are necessary to detect minimal disease and secondary malignant lesions. The patients with MCD should be candidates for multimodality therapy.
6.Determination of palmatine hydrochloride and berberine hydrochloride in Chinese Mahonia Stem from different habitats by HPLC
Jie HUANG ; Tong SANG ; Hongping QIN ;
Chinese Traditional and Herbal Drugs 1994;0(06):-
Object To develop a method for the determination of palmatine hydrochloride and berberine hydrochloride in Chinese Mahonia Stem from different habitats Methods HPLC method was set up, using Intersil ODS 3 C 18 column, the mobile phase was acetontrile water sodium laurylsulfonate (470∶ 530∶1 g), the UV detection wavelength was 265 nm, with a flow rate of 1 0 mL/min at 40 ℃ Results A good linearity was obtained in the range of 4 368 52 416 ?g/mL(r=0 999 9) for palmatine hydrochloride and 4 532 54 384 ?g/mL (r=0 999 9) for berberine hydrochloride The average recovery of palmatine hydrochloride and berberine hydrochloride was 98 97% and 98 98%, respectively Conclusion The method is simple, rapid and with better reproducibility for the determination of palmatine hydrochloride and berberine hydrochloride in Chinese Mahonia Stem
7.Clinical efficacy and safety of ravidavir-based antiretroviral regimen in treatment of patients with chronic hepatitis C
Mengqiu XU ; Yaling TONG ; Jianrong HUANG
Chinese Journal of Clinical Infectious Diseases 2021;14(1):75-80
China has largest number of chronic hepatitis C (CHC) patients, with complex distribution of genotypes, high proportion of refractory types and low diagnosis and treatment rate. It is necessary to explore accessible pan-genotype antiviral treatment protocols with high cure rate. Currently, the direct acting antiviral agents (DAAs) are recommended as the main treatment regimes by international guidelines for hepatitis C. Ravidasvir (RDV) is a new generation of NS5a inhibitor, which can be widely used in treatment of gene type 1, 2, 3, 4 and 6 CHC with strong antiviral activity and high resistance barrier. A number of clinical studies demonstrate that the combination of ravidavir with DAA S, such as second-generation protease inhibitor danoprevir (DNV) and nucleoside NS5b inhibitor sofosbuvir (SOF) have gained high cure rate and good safety for CHC patients. In this article, the results of related studies on ravidavir-based antiretroviral regimens in treatment of CHC are reviewed.
8.Effects of atrial fibrillation on expressions of connexin40 and connexin43 in atrial myocytes in rheumatic heart disease patients
Ji HUANG ; Zhiyuan SONG ; Shifei TONG
Journal of Third Military Medical University 2003;0(19):-
6 months (n=12), control group, without AF (n=8). Atrial muscle samples of the left and right atrial appendage were cut off during heart valve replacement. Expressions of Cx40 and Cx43 were detected by immunoblotting and immunohistologic analyses. Results ①No obvious change of Cx43 and Cx40 in the left and right atrium of each patient in each group was measured. ②Compared with that in the control group, the level of Cx40 was decreased signficantly in GroupⅠ (P
9.Morphological changes of left and right atrial myocytes in rheumatic heart disease patients with atrial fibrillation
Ji HUANG ; Zhiyuan SONG ; Shifei TONG
Journal of Third Military Medical University 1984;0(01):-
6 months; Control group (n=8) without AF. Atrial muscle samples of the left and right atrial appendage were cut off during heart valve replacement. Morphological changes were observed by light microscopy and electron microscopy. Results ① The incidence rates of Aschoff body were 37.5% (3/8), 46% (5/11) , and 50% (6/12) in Group Ⅰ, Group Ⅱ, and the control group. There was no difference in Aschoff body between the left and right atrial myocytes. ② There was no difference in myocytic degeneration, interstitial hyperplasia, and lymphocytes infiltration between the left and right atrial myocytes in each group. ③ Myolysis, accumulation of glycogen, and fibrosis were detected by electron microscopy in the 3 groups. Changes of myolysis and fibrosis were more obvious in patients with AF than patients without AF. Conclusion There are similar pathological changes in the left and right atria in rheumatic heart disease patients with or without AF. Fibrosis of atrial myocytes may be involved in the occurrence and maintenance of AF.